FDA approves updated COVID-19 boosters

Editor's Note

The Food and Drug Administration (FDA), on September 11, approved the Moderna and Pfizer/BioNTech updated COVID-19 boosters that target the Omicron subvariant XBB.1.5, the September 11 Reuters reports.

The boosters, which were approved for those 12 years and older and authorized for emergency use for children ages 6 months to 11 years, must now be signed off by a Centers for Disease Control and Prevention (CDC) advisory panel.

The vaccines will be free for most Americans with health insurance, and the US government is working on a program to provide the vaccines for free to those without insurance, the report says.